SEC EDGAR Filing Information

Form 3 -- Initial statement of beneficial ownership of securities

Period of Report: 2008-11-26
Filing Date Changed: 2008-12-03
Documents: 1

SEC Accession No.
0001140361-08-027009
Filing date: 2008-12-03
Accepted: 2008-12-03 16:49:45

Table of submitted documents:

Seq	Type	Document	Size	Description
1	3	doc1.html		FORM 3
1	3	doc1.xml	2864	FORM 3

		0001140361-08-027009.txt	4789	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Issuer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628

CAVAZZA CLAUDIO (Reporting) (0001164803)
Type: 3 | Act: 34 | File No.: 000-16929 | Film No.: 081227918

Business Address

Mailing Address
VIA SUDAFRICA 20
ROME ITALY L6 00000